ResearcherShenyang Pharmaceutical UniversityNo recent work listed

Haoqiang Huang

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0009-0007-2309-220X; OpenAlex author ID A5114339955.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells. First author DOI 10.1016/j.bmcl.2022.129087 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Juanping Zhao · 1 shared paper, 2023
- Paper Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer c… DOI 10.1016/j.bmcl.2022.129087 ↗
Lei Yuan · 1 shared paper, 2023
- Paper Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer c… DOI 10.1016/j.bmcl.2022.129087 ↗
Enlong Ma · 1 shared paper, 2023
- Paper Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer c… DOI 10.1016/j.bmcl.2022.129087 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.